According to the literature, the positive rate of RNS in patients with MG who are double-positive for AChR/LRP4 antibodies is significantly higher than that observed in patients who are double-positive for MuSK/LRP4 antibodies. This evidence concerns the gene MUSK and myasthenia gravis.